Acarix A/S (ACARIX) - Total Liabilities
Based on the latest financial reports, Acarix A/S (ACARIX) has total liabilities worth Skr10.16 Million SEK (≈ $1.09 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Acarix A/S (ACARIX) cash conversion ratio to assess how effectively this company generates cash.
Acarix A/S - Total Liabilities Trend (2014–2025)
This chart illustrates how Acarix A/S's total liabilities have evolved over time, based on quarterly financial data. Check ACARIX asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Acarix A/S Competitors by Total Liabilities
The table below lists competitors of Acarix A/S ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cipherlab Co Ltd
TWO:6160
|
Taiwan | NT$426.98 Million |
|
Gol Linhas Aéreas Inteligentes S.A
NYSE:GOLLQ
|
USA | $45.83 Billion |
|
POLARIS WORKS Inc
KQ:123010
|
Korea | ₩21.88 Billion |
|
Gabriel Resources Ltd
V:GBU
|
Canada | CA$23.73 Million |
|
Mendus AB (publ)
ST:IMMU
|
Sweden | Skr43.26 Million |
|
Sterling Metals Corp
V:SAG
|
Canada | CA$310.10K |
|
Subur Tiasa Holdings Bhd
KLSE:6904
|
Malaysia | RM748.15 Million |
Liability Composition Analysis (2014–2025)
This chart breaks down Acarix A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ACARIX market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 1.80 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Acarix A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Acarix A/S (2014–2025)
The table below shows the annual total liabilities of Acarix A/S from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr10.16 Million ≈ $1.09 Million |
+100.61% |
| 2024-12-31 | Skr5.06 Million ≈ $544.97K |
-53.96% |
| 2023-12-31 | Skr11.00 Million ≈ $1.18 Million |
-37.70% |
| 2022-12-31 | Skr17.66 Million ≈ $1.90 Million |
-2.22% |
| 2021-12-31 | Skr18.06 Million ≈ $1.94 Million |
+131.14% |
| 2020-12-31 | Skr7.81 Million ≈ $840.70K |
+22.46% |
| 2019-12-31 | Skr6.38 Million ≈ $686.48K |
-12.86% |
| 2018-12-31 | Skr7.32 Million ≈ $787.75K |
+43.05% |
| 2017-12-31 | Skr5.12 Million ≈ $550.67K |
-71.20% |
| 2016-12-31 | Skr17.77 Million ≈ $1.91 Million |
+416.12% |
| 2015-12-31 | Skr3.44 Million ≈ $370.52K |
+8.92% |
| 2014-12-31 | Skr3.16 Million ≈ $340.17K |
-- |
About Acarix A/S
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauri… Read more